News

Food giant Kraft Heinz vows to stop using artificial dyes
Kraft Heinz says it will stop using artificial food dyes by 2027, replacing them with natural versions or taking other steps, ...
New FDA Chief Wants to Fast-Track Some Drugs, Use More AI
FDA Commissioner Marty Makary faces declining staff morale as he remakes the agency.
We Spent a Year Investigating How the FDA Let Risky Drugs Into the U.S. Market
Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into ...
A new chapter for online sales of obesity drug alternatives tests legal limits
While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...
‘Gas station heroin’ is technically illegal and widely available. Here are the facts
Sometimes called “gas station heroin,” the products are usually marketed as energy shots or cognitive supplements but ...
FDA Plans to Use AI to Speed Up Drug and Food Safety Reviews
WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial ...
US FDA extends review of KalVista's swelling disorder drug due to heavy workload
KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had extended the review of its drug for a ...
MIT Technology Review4d
Here’s what food and drug regulation might look like under the Trump administration
Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...
Hub1h
Life-changing food allergy management drug made possible by NIH funding
The Johns Hopkins-led and NIH funded OUtMATCH study led to the development of Xolair, a groundbreaking drug that reduces the ...
Elon Musk passes ketamine test—here’s what the drug is and why it raised eyebrows
Elon Musk faced controversy after accusations of heavy ketamine use during his time in the Trump administration. He responded ...
Capricor Therapeutics' Becker Muscular Dystrophy Drug Gets Orphan Drug Designation in U.S.
Capricor Therapeutics has received an orphan drug designation for its drug aimed at potentially treating Becker Muscular Dystrophy. The biotechnology company said Tuesday that the Food and Drug ...